
What is H5N1? Experts warn virus spreading across US, fears of new pandemic
Show Caption
Hide Caption
Are we ready for a bird flu pandemic?
There's a growing body of evidence that suggests people may have asymptomatic bird flu infections.
Experts warn about the possibility of a new pandemic in 2025 as bird flu spreads across all 50 states, impacting American dairy and poultry farms with dozens of people infected.
Here's what to know.
Bird flu, also known as H5N1, has been around for decades. But the discovery in 2024 that the virus spread from wild birds to cows came as a surprise to public health experts, according to officials. In just over a year, the virus has ravaged America's dairy herds and poultry flocks and has infected humans − sometimes causing death.
The Global Virus Network (GVN), a nonprofit coalition of virologists, has issued warnings to governments to address the threat of the H5N1 outbreak by improving surveillance, implementing biosecurity measures, and preparing for potential human-to-human transmission.
"Understanding the current landscape of H5N1 infections is critical for effective prevention and response," said Dr. Sten H. Vermund, chief medical officer of the GVN and an infectious disease epidemiologist. "The virus' ability to infect both animals and humans, combined with recent genetic changes, underscores the importance of proactive surveillance and rapid response measures.'
How much has bird flu spread?
In the United States, the outbreak has affected over 1,000 dairy herds across 17 states, according to U.S. Department of Agriculture data. It has caused the loss or culling in commercial and backyard poultry flocks of more than 169 million birds since 2022, USDA said.
Federal health officials have identified 70 people in the United States infected, mostly among dairy and poultry workers, according to the Centers for Disease Control and Prevention. One person, an older Louisiana resident with underlying medical issues, died in January, becoming the first American death from bird flu. The strain of bird flu the Louisiana resident had, known as D1.1, has been known to cause severe illness in humans.
Bird flu has shown to be concerning elsewhere in North America. In early April 2024, Mexican officials confirmed the country's first bird flu death in a 3-year-old girl. In November 2024, Canadian officials identified a 13-year-old girl who became severely ill with the D1.1 strain and had to be intubated.
'In the U.S. sporadic human infections with no known contact with infected animals highlight the possibility of viral adaptation for efficient human-to-human transmission,' GVN scientists said in a report. 'Concurrently, the virus continues to circulate in wild birds, backyard flocks, and hunted migratory species, further amplifying the risk to humans and domestic animals.'
Dr. Kay Russo, a veterinarian, warned in an interview that time to stop the bird flu is 'running out.' She told CBS News that while it's not clear how the virus was spreading from cow to cow, 'milking equipment is a prime suspect' and workers in milking parlors have also fallen sick with flu-like symptoms.
Infectious disease physician Dr. Kamran Khan said in the same interview, that his company, BlueDot, was among the first to flag the virus in China that became the COVID pandemic. He said 'the bird flu is just as concerning' and explained how fast the virus has spread among dairy cattle.
What is H5N1?
H5N1, also known as highly pathogenic avian influenza, is a specific strain of influenza A virus. Bird flu is a highly contagious respiratory disease that primarily affects birds, but can also infect other animals, including mammals like dairy cows and humans.
Chickens are highly susceptible to illness and death, while cows appear to recover. Humans have often had mild symptoms, though a few cases have caused serious illness.
Experts have warned that if the virus continues to spread across species, it increases the likelihood of becoming more transmissible to humans and causing more severe illness.
What are the symptoms of H5N1 infection in humans?
The symptoms of H5N1 infection may include fever (often high fever, over 100.4 degrees) and malaise, cough, sore throat and muscle aches. Other early symptoms may include conjunctivitis and other non-respiratory symptoms.
The infection may progress quickly to severe respiratory illness, pneumonia and neurologic changes (altered mental status or seizures), according to the World Health Organization.
Eduardo Cuevas of USA TODAY contributed to this report.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Hill
39 minutes ago
- The Hill
Most adults do not plan on getting COVID-19 shot amid vaccine policy changes
More than half of American adults — 59 percent — say they do not expect to get the COVID-19 booster shot this autumn, according to new poll findings from healthcare policy group KFF. Poll results show that 23 percent of U.S. adults say they will 'probably not' get the vaccine, while 37 percent will 'definitely not' get the shot. Americans who said they will 'probably' or 'definitely' not get the shot were also more likely to say they think changes to U.S. vaccine policy are 'major' and will make people less safe. The data comes as the Trump administration makes drastic changes to the country's vaccine policy. Secretary for the Department of Health and Human Services Robert F. Kennedy Jr. announced earlier this year that the COVID-19 shot will no longer be recommended for healthy children and pregnant women. Kennedy also abruptly fired all 17 members of an independent vaccine advisory panel for the Centers for Disease Control and Prevention in June. He then replaced the panel with eight hand-picked appointees, many of whom have expressed vaccine skepticism in the past. Adults who identify as Republicans are far less likely to plan on getting the vaccine compared to those who identify as Democrats. About six out of 10 Republicans said they would 'definitely not' get the shot compared to about one out of 10 Democrats, according to the poll. White adults are the most likely to say that they are against getting the vaccine once the colder months arrive with about four out of 10 admitting they will 'definitely not' get the shot. Meanwhile, 32 percent of Black adults say they will 'definitely not' get the COVID-19 vaccine this fall, along with 30 percent of adults who identify as Hispanic. Adults between the ages of 30 and 49 are the most likely to say that they do not plan on getting the vaccine, with 42 percent of that age group saying they will 'definitely not' get the shot in the fall. The U.S. appears to be experiencing another summer wave of COVID-19 cases. As of July 29, COVID-19 infections are growing or likely growing in 40 states, including Florida, Texas, and New York, according to the CDC. The KFF poll was conducted via a national representative survey of about 1,300 people between July 8-14.


Hamilton Spectator
an hour ago
- Hamilton Spectator
Justin Timberlake reveals ‘relentlessly debilitating' Lyme disease symptoms — Do you live in Ontario's high risk areas?
Justin Timberlake has Lyme disease. The famous pop star confirmed his battle with 'relentlessly debilitating' Lyme disease symptoms in an Instagram post Thursday . 'When I first got the diagnosis I was shocked for sure,' he wrote. 'But, at least I could understand why I would be onstage and in a massive amount of nerve pain or, just feeling crazy fatigue or sickness.' Timberlake faced criticism for recent performances in Europe over what fans described as low-energy shows. It appears Lyme disease may be to blame. 'I was faced with a personal decision. Stop touring? Or, keep going and figure it out,' Timberlake wrote on Instagram. 'I decided the joy that performing brings me far outweighs the fleeting stress my body was feeling. I'm so glad I kept going.' Timberlake just completed his 'Forget Tomorrow World Tour' in Istanbul, Turkey on Tuesday. The tour started in Vancouver last April. A post shared by Justin Timberlake (@justintimberlake) Notable Canadian celebrities who have shared their diagnosis with Lyme disease include Avril Lavigne, Justin Bieber and Shania Twain. The blacklegged tick is known to transmit four tick-borne diseases — anaplasmosis, babesiosis, Lyme disease and Powassan virus — that are listed as Diseases of Public Health Significance by Public Health Ontario (PHO). Lyme disease occurs in stages. Symptoms can vary from person to person after being bitten by an infected blacklegged tick or western blacklegged tick. Signs and symptoms of each stage can overlap. 'In some people, Lyme disease may present in a later stage without a history of prior signs or symptoms,' the Public Health Agency of Canada (PHAC) explains. Early signs and symptoms of Lyme disease can manifest as: The erythema migrans rash is the most commonly reported sign of Lyme disease. PHAC explains it's an expanding skin rash that usually starts at the site of the tick bite slowly expanding over several days. The rash can be circular or oval-shaped, looking like a target or bull's eye. It can go unnoticed if it's on dark skin or a part of the body that's hard to see. PHAC says some people might not develop a rash at all. The bull's-eye shape of this rash is a clear sign of Lyme disease. Later symptoms of Lyme disease can appear days to months after an infected tick bite and might manifest as: In very rare cases, death can occur due to the complications involving an infection of the heart. Lyme disease is a growing concern in Canada particularly in southern Ontario, which is considered one of a few hot spots for ticks. Tick populations continue to climb in Ontario, as well as other parts of Canada. This year is expected to follow the trend . The Public Health Agency of Canada has a tool where you can type in your postal code and it will tell you if you're located in a risk area for Lyme disease. Some risk areas include spots in Windsor, Whitby, Waterloo, Uxbridge, The Blue Mountains, Tay Valley, St. Catharines, Smiths Falls, Scugog, Richmond Hill, Rideau Lakes, Renfrew, Prince Edward County, Port Hope, Perth, Peel, Ottawa, Oshawa, Orillia, Oakville, Niagara Falls, Newmarket, Mississauga, Milton, Markham, Hamilton, Clarington, Caledon, Burlington, Brampton, Kawartha Lakes, Barrie, Ajax and more. Map of five areas known for risk to tick exposure in Canada. The number of human reported Lyme disease cases in Canada in 2024 was 5,239, according to preliminary data from the PHAC. That's a jump from the 4,785 cases reported in 2023 and 2,525 in 2022. For a matter of perspective, only 144 cases were reported in 2009. Out of the 4,785 cases in 2023, 1,865 were reported in Ontario, according to Public Health Ontario data. In Canada, Lyme disease is caused by a bacterium called Borrelia burgdorferi, which is spread through the bite of infected blacklegged ticks — also known as deer ticks — and western blacklegged ticks, according to the PHAC. The blacklegged tick, or deer tick as it is sometimes called, is the most common carrier of Lyme disease. Despite the established risk areas for ticks, Public Health Ontario said it's important for people to know they could encounter an infected blacklegged tick almost anywhere in Ontario , as blacklegged ticks feed on and are transported by migratory birds. Species of ticks can be found in most parts of Ontario — clustering along the north shores of Lake Erie, Lake Ontario and the St. Lawrence River, according to PHO. This map depicts the estimated risk areas for Lyme disease in Ontario in 2024. Risk areas for Lyme disease in southern Ontario can be found along the north shores of Lake Erie and Lake Ontario and on the south shore of Lake Huron, according to PHAC . In southeastern Ontario, risk areas can be found around Kingston in the St. Lawrence valley, extending northeast toward Ottawa. PHO data shows Lyme disease was reported in all but one health unit region in 2023. The highest concentration of reported cases in Ontario in 2013 was in the Ontario health unit catchment areas of Hastings Prince Edward Public Health and Kingston, Frontenac, Lennox & Addington Public Health. In 2023, 84 people in Ontario were hospitalized for Lyme disease. PHO shows Lyme rates have been climbing for the last 10 years. Climate change is contributing to the spread of blacklegged ticks to new areas in Canada. Southern, western and southeastern Ontario, parts of Manitoba, southern Quebec and the Maritime provinces are known to be risk areas for ticks and Lyme disease exposure. Map of five areas known for risk to tick exposure in Canada. Lyme disease and other tick-borne illnesses can cause serious medical issues. Here are some proactive measures to take to avoid getting bitten by a tick. For more information on ticks , visit the Public Health Agency of Canada's website. Error! Sorry, there was an error processing your request. There was a problem with the recaptcha. Please try again. You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy . This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply. Want more of the latest from us? Sign up for more at our newsletter page .


Hamilton Spectator
an hour ago
- Hamilton Spectator
CNL and Partners Identified Three Canadian Locations to Advance the Design of Renewable Diesel Production Facilities
CHALK RIVER, Ontario, Aug. 01, 2025 (GLOBE NEWSWIRE) — Canadian Nuclear Laboratories (CNL), Canada's premier nuclear science and technology laboratory, in partnership with Expander Energy Inc. (Expander), Fuel Cell Energy (FCE), St Marys Cement (SMC), and Nuclear Promise X (NPX), are pleased to announce that they have identified three Canadian locations as potential sites for the location of renewable diesel production facilities. These facilities would be capable of converting wood waste feedstock into 90 million litres of 'drop-in ready' renewable diesel fuel per year, transforming a waste product into a valuable, low-carbon fuel for the transportation sector. This milestone follows the successful completion of a feasibility study, funded through Natural Resources Canada's (NRCan) Clean Fuels Fund, which demonstrated the economic viability of synthetic diesel production using biomass through water electrolysis. The concept, known as 'e-Syn', encompasses the use of water and water electrolysis as part of an innovative, patented and patent pending process for making bio-synthetic fuels developed by CNL and Expander, called the Biomass Electrolysis to Liquids (BETL™) technology. The project leverages Expander's technology for biomass gasification and bio-synthetic fuel production, and electrolysis technology. The resulting fuel (either bio-synthetic diesel, known as Bio-SynDiesel®, or bio-synthetic aviation fuel, known as Bio-SynJet®) will be comprised entirely of carbon sourced from biogenic (atmospheric) sources, and is expected to have very low life cycle carbon intensity. As part of the feasibility study, a number of potential sites in Canada were evaluated with the intent of selecting one site for a Front-End Engineering Design (FEED) phase of the project. This process culminated in the selection of three locations at sites in British Columbia, Ontario and Quebec, all of which fulfill the necessary requirements in terms of proximity to utilities, and accessibility to major roads and key resources like biomass, among other factors. Following NRCan's approval, the feed study was extended from one to the three sites, a process that is expected to be completed in the Fall of 2025. 'CNL is thrilled at the results that were generated through the feasibility study and is ready to move into the next phase of the project, which has the potential to eventually produce economical, ready-to-deploy, renewable diesel fuel,' commented Stephen Bushby, CNL's Vice-President of Science and Technology. 'As Canada moves towards a net-zero future, synthetic transportation fuels provide an immediate opportunity for the country to reduce its greenhouse gas emissions, with the additional benefit of leveraging waste, such as wood, that may otherwise go to waste. The transportation sector in Canada is responsible for almost 25 per cent of the country's total emissions, so this innovation has the potential to make an important impact toward decarbonizing that sector, as well as Canada's overall carbon footprint.' 'This is not a science experiment – the feasibility study showed that the BETL™ technology can efficiently produce bio-synthetic fuels at prices competitive with existing food competitive Hydrogenation-Derived Renewable Diesel (HDRD) and Hydroprocessed Esters and Fatty Acids (HEFA) fuels,' commented Gord Crawford, Expander's President and CEO. 'Preliminary economic assessments indicated strong financial performance for all three sites. For future opportunities to actually deploy this technology, Expander and CNL plan to install a commercially proven electrolyzer as part of the planned Expander Carseland Alberta Gasifier project in order to technically and commercially derisk potential investment in the three sites under development in the CFF program.' The engineering design work will be based on the utilization of 240 dry tonnes of forestry wood waste per day as feedstock to annually produce approximately 30 million liters of renewable diesel per processing facility by using the BETL™ technology. The design of these facilities could also serve as a template for future sites, both nationally and internationally, using a build, own and operate model. Site specific details will be announced in coordination with local partners, including government and Indigenous nations and organizations, in the near future. The relevance of this project is timely in Canada. While increasing the supply of low-carbon electricity, including nuclear generation and other renewable power options, will be critical to reaching Canada's net zero target, synthetic liquid fuels provide an immediate opportunity to decarbonize marine, aviation and other heavy duty transport sectors using existing engines. These clean fuels are 'drop in' ready, providing an attractive opportunity to decarbonize without the need to make major changes to engine design and manufacturing processes. Converting cellulosic biomass, such as lumber mill and forest residues, to synthetic diesel or sustainable aviation fuel, is also an attractive and promising method to produce fuel that complies with North America's ASTM D975 and Europe's CEN 15940 diesel specifications. Several investors, including major offtakers, have expressed interest in participating in any potential projects. About CNL As Canada's premier nuclear science and technology laboratory and working under the direction of Atomic Energy of Canada Limited (AECL), CNL is a world leader in the development of innovative nuclear science and technology products and services. Guided by an ambitious corporate strategy known as Vision 2030, CNL fulfills three strategic priorities of national importance – restoring and protecting the environment, advancing clean energy technologies, and contributing to the health of Canadians. By leveraging the assets owned by AECL, CNL also serves as the nexus between government, the nuclear industry, the broader private sector and the academic community. CNL works in collaboration with these sectors to advance innovative Canadian products and services towards real-world use, including carbon-free energy, cancer treatments and other therapies, non-proliferation technologies and waste management solutions. To learn more about CNL, please visit . About Expander Energy Inc. Expander Energy Inc. is a Calgary, Alberta based energy technology company that has developed a patented suite of transportation fuel production technologies to convert biomass and low Carbon Intensity electricity into 'Fossil Free' Low Life Cycle Carbon Intensity synthetic diesel fuel (Bio-SynDiesel®) and synthetic kerosene jet fuel (Bio-SynJet®). Expander's Bio-Energy Carbon Capture and Sequestration (BECCS) solution utilizes cellulosic biomass to produce next generation low CI synthetic fuels while efficiently capturing bio-carbon for geologic sequestration. Bio-SynDiesel®, Bio-SynJet®, BGTL™, EBTL™, BETL™, and CETL™ are trademarks of Expander Energy Inc. To learn more about Expander, please visit . About Nuclear Promise X Nuclear Promise X (NPX) is a forward-thinking Canadian tech start-up, established in 2018, with a mission to transform the nuclear industry through cutting-edge solutions and address the climate crisis. NPX focuses on integrating advanced technology into nuclear plant operations to enhance efficiency, reduce costs, and promote sustainability. To learn more about Nuclear Promise X, please visit . About Fuel Cell Energy Inc. FuelCell Energy, Inc. is a global leader in sustainable energy technologies that address some of the world's most critical challenges around energy, safety, and global urbanization. It collectively holds 531 fuel cell technology patents in the United States and globally. As a leading global manufacturer of proprietary fuel cell technology platforms, FuelCell Energy is uniquely positioned to serve customers including businesses, utilities, governments, and municipalities with sustainable products and solutions. The company's solutions are designed to enable a world empowered by sustainable energy, enhancing the quality of life for people around the globe. Learn more at . About St Marys Cement St Marys Cement is part of Votorantim Cimentos, a global vertically integrated aggregate, cement and concrete solutions provider. With sustainability as a strategic driver, Votorantim Cimentos has committed to ambitious decarbonization goals, including net-zero concrete by 2050 as defined by the GCCA (Global Cement and Concrete Association). As one of its key milestones, the company has set a global 2030 decarbonization target of 475 kg of CO2 per tonne of cement, representing a 24.8% reduction compared to the 2018 baseline year. This target has been approved and verified by the Science Based Target initiative (SBTi). The company works together with industry to reduce emissions and tackle climate change, executing several initiatives simultaneously, including increasing the use of alternative fuels; investing in product innovations with lower clinker content; evaluating carbon capture and utilization technologies; increasing energy efficiency; fostering the circular economy; and participating in the construction of energy-efficient buildings. To learn more about St Marys Cement, please visit: . CNL Contact: Philip Kompass Director, Corporate Communications media@